These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29908442)

  • 41. Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring.
    Bonifazi A; Del Bello F; Mammoli V; Piergentili A; Petrelli R; Cimarelli C; Pellei M; Schepmann D; Wünsch B; Barocelli E; Bertoni S; Flammini L; Amantini C; Nabissi M; Santoni G; Vistoli G; Quaglia W
    J Med Chem; 2015 Nov; 58(21):8601-15. PubMed ID: 26430967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N-[(Tetrahydrofuryl)alkyl] and N-(alkoxyalkyl) derivatives of (-)-normetazocine, compounds with differentiated opioid action profiles.
    Merz H; Stockhaus K
    J Med Chem; 1979 Dec; 22(12):1475-83. PubMed ID: 43894
    [No Abstract]   [Full Text] [Related]  

  • 43. Synthesis and pharmacology of 5-noralkyl-9beta-methyl-6,7-benzomorphans and stereochemistry of some intermediates.
    Inoue H; O-ishi T; May EL
    J Med Chem; 1975 Aug; 18(8):787-91. PubMed ID: 808610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.
    Manallack DT; Wong MG; Costa M; Andrews PR; Beart PM
    Mol Pharmacol; 1988 Dec; 34(6):863-79. PubMed ID: 2849051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and pharmacological studies of 2'-sulphonyl[3-(3H-2,4-disubstituted-1,5-benzodiazepino)]-2,5-dimethyl-6,7-benzomorphans.
    Pant J; Pant KK; Gupta TK; Bhargava KP; Joshi BC
    Pharmazie; 1982 Mar; 37(3):176-7. PubMed ID: 7100235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted κ-opioid receptor agonists.
    Bourgeois C; Werfel E; Galla F; Lehmkuhl K; Torres-Gómez H; Schepmann D; Kögel B; Christoph T; Straßburger W; Englberger W; Soeberdt M; Hüwel S; Galla HJ; Wünsch B
    J Med Chem; 2014 Aug; 57(15):6845-60. PubMed ID: 25062506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Scouting new sigma receptor ligands: Synthesis, pharmacological evaluation and molecular modeling of 1,3-dioxolane-based structures and derivatives.
    Franchini S; Battisti UM; Prandi A; Tait A; Borsari C; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Parenti C; Brasili L
    Eur J Med Chem; 2016 Apr; 112():1-19. PubMed ID: 26874044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition by sigma receptor ligand, MS-377, of N-methyl- D-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area.
    Yamazaki Y; Ishioka M; Matsubayashi H; Amano T; Sasa M
    Psychopharmacology (Berl); 2002 Apr; 161(1):64-9. PubMed ID: 11967632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective.
    Fallica AN; Pittalà V; Modica MN; Salerno L; Romeo G; Marrazzo A; Helal MA; Intagliata S
    J Med Chem; 2021 Jun; 64(12):7926-7962. PubMed ID: 34076441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tricycloundecane Derivatives as Potential N-Methyl-D-aspartate (NMDA) Receptor and Voltage-Gated Calcium Channel Modulators.
    Egunlusi AO; Malan SF; Joubert J
    ChemMedChem; 2015 Jul; 10(7):1259-66. PubMed ID: 26012541
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigating isoindoline, tetrahydroisoquinoline, and tetrahydrobenzazepine scaffolds for their sigma receptor binding properties.
    Linkens K; Schmidt HR; Sahn JJ; Kruse AC; Martin SF
    Eur J Med Chem; 2018 May; 151():557-567. PubMed ID: 29656199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro neuroprotection by substituted guanidines with varying affinities for the N-methyl-D-aspartate receptor ionophore and for sigma sites.
    Kirk CJ; Reddy NL; Fischer JB; Wolcott TC; Knapp AG; McBurney RN
    J Pharmacol Exp Ther; 1994 Nov; 271(2):1080-5. PubMed ID: 7525936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex.
    Matsuno K; Matsunaga K; Senda T; Mita S
    J Pharmacol Exp Ther; 1993 May; 265(2):851-9. PubMed ID: 8496830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of 4-(aminoalkyl) substituted 1,3-dioxanes as potent NMDA and σ receptor antagonists.
    Utech T; Köhler J; Wünsch B
    Eur J Med Chem; 2011 Jun; 46(6):2157-69. PubMed ID: 21444132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stereoselective synthesis of benzomorphan derivatives with perpivaloylated galactose as the chiral auxiliary.
    Klegraf E; Knauer S; Kunz H
    Angew Chem Int Ed Engl; 2006 Apr; 45(16):2623-6. PubMed ID: 16548042
    [No Abstract]   [Full Text] [Related]  

  • 56. Synthesis and biological evaluation of novel 6,7-dihydro-5H-cyclopenta[d]pyrimidine and 5,6,7,8-tetrahydroquinazoline derivatives as sigma-1 (σ1) receptor antagonists for the treatment of pain.
    Lan Y; Songyang Y; Zhang L; Peng Y; Song J
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2051-6. PubMed ID: 26947609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
    Whittemore ER; Ilyin VI; Woodward RM
    J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and structure-activity relationship study of a new series of selective σ(1) receptor ligands for the treatment of pain: 4-aminotriazoles.
    Díaz JL; Christmann U; Fernández A; Torrens A; Port A; Pascual R; Álvarez I; Burgueño J; Monroy X; Montero A; Balada A; Vela JM; Almansa C
    J Med Chem; 2015 Mar; 58(5):2441-51. PubMed ID: 25658964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl)methyl with N-phenyl-N-(piperidin-2-yl)propionamide derivatives as opioid ligands.
    Deekonda S; Rankin D; Davis P; Lai J; Vanderah TW; Porecca F; Hruby VJ
    Bioorg Med Chem; 2016 Jan; 24(2):85-91. PubMed ID: 26712115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Herrero-Labrador R; Burgueño J; Zamanillo D; Garzón J
    Int J Neuropsychopharmacol; 2014 Dec; 17(12):1943-55. PubMed ID: 24485144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.